Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rESP for Anemia in Hemodialysis Patients
NCT03950687Phase 2Unknown
- Sponsor
- 3SBio
- Start
- Jun 2019
- Primary completion
- Jun 2020
- Modality
- PEGylated Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of SSS06 in anemia (3 arms), sponsored by 3SBio. Primary endpoint: Primary efficacy index: hemoglobin concentration. Status: unknown.
02
Drugs
SSS06
03
Conditions
anemia
Beyond the preview
Go deeper on NCT03950687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03950687.